(Oslo, 5th of April 2022) Medistim ASA (OSE: MEDI) is a niche market leader within ultrasound technology with headquarters in Oslo, Norway. Medistim develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery.
Medistim is proud to announce that our CEO, Kari E. Krogstad, has been named as the winner of the Arthur D. Little’s Nordic Life Science Award for 2021. The prize was awarded at a ceremony in Stockholm on April 4, 2022.
…
Vis børsmeldingen
The Arthur D. Little Nordic Life Science Award is given to a person in the Nordic region that has demonstrated outstanding management and leadership in the Life Science industry. The business shall be built on a strong entrepreneurship and a high scientific level. The prize is awarded annually since 2002.
“With a persistent, international, and long-term perspective, Kari has successfully built Medistim to become a global niche market leader within ultrasound technology, systematically moving the company from technology oriented to customer/market focused. Also, being highly active on the Norwegian life science scene over many years and having dedicated her whole career to the industry, Kari is a true source of inspiration to many life science professionals in the Nordics,” says Ulrica Sehlstedt, Managing Partner and Global Head of Healthcare and Life Sciences in Arthur D. Little.
“I am honored by this recognition, and it adds to my motivation for doing what I love the most; working with the most talented and inspiring people; my colleagues, our customers and business partners, in delivering both clinical and financial value from supporting the world’s best cardiovascular surgeons with the ultrasound tools they need,” says Kari Krogstad. “I share this award with the whole team at Medistim and thank them for all our achievements thus far. There is more to come. Thanks to Arthur D. Little for having instituted this Nordic Life Science Award. It provides a stage to highlight the companies and people in an industry that has great prospects for growing value creation for investors, as well as society as a whole. “
About Medistim:
Medistim was established in 1984 and has a track record of profitable growth over the past 20 years. The company is a pioneer within its segment and continues to invest in new product development. Medistim has wholly owned subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark, and Norway, in addition to the about 50 distributors in Europe, Asia, Middle East, Africa, Canada and South America. For more information, visit the Medistim home page: www.medistim.com
About Arthur D. Little:
Arthur D. Little has been at the forefront of innovation since 1886 and has worked with healthcare and life sciences companies since its inception. The company is an acknowledged thought leader in linking strategy, innovation and transformation in technology-intensive and converging industries and is today established in more than 30 countries. The Nordic business was established in 1993 and has today offices in Stockholm, Gothenburg and Oslo. For further information, please visit www.adlittle.com
For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com
CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com
Kilde
